Literature DB >> 27075848

Diagnostic investigation of new disease syndromes in farmed Australian saltwater crocodiles (Crocodylus porosus) reveals associations with herpesviral infection.

Catherine M Shilton1, Ian V Jerrett2, Steven Davis2, Susan Walsh2, Suresh Benedict2, Sally R Isberg2, Grahame J W Webb2, Charlie Manolis2, Timothy H Hyndman2, David Phalen2, Gregory P Brown2, Lorna Melville2.   

Abstract

Since 2006, 3 new disease syndromes have emerged in farmed saltwater crocodiles (Crocodylus porosus) in the Northern Territory of Australia. We describe the syndromes through a retrospective study of laboratory findings from 187 diagnostic cases submitted to Berrimah Veterinary Laboratories between 2005 and 2014. The first syndrome was characterized by conjunctivitis and/or pharyngitis (CP), primarily in hatchlings. Herpesviruses were isolated in primary crocodile cell culture, or were detected by PCR directly from conjunctiva or pharyngeal tissue, in 21 of 39 cases of CP (54%), compared with 9 of 64 crocodiles without the syndrome (14%, p < 0.0001). Chlamydiaceae were detected by PCR in conjunctiva or pharyngeal tissue of 55% of 29 CP cases tested, and of these, 81% also contained herpesvirus. The second syndrome occurred in juveniles and growers exhibiting poor growth, and was characterized histologically by systemic lymphoid proliferation and nonsuppurative encephalitis (SLPE). Herpesviruses were isolated or detected by PCR from at least 1 internal organ in 31 of 33 SLPE cases (94%) compared with 5 of 95 crocodiles without the syndrome (5%, p < 0.0001). The third syndrome, characterized by multifocal lymphohistiocytic infiltration of the dermis (LNS), occurred in 6 harvest-sized crocodiles. Herpesviruses were isolated from at least 1 skin lesion in 4 of these 6 cases. Although our study revealed strong associations between herpesvirus and the CP and SLPE syndromes, the precise nature of the role of herpesvirus, along with the pathogenesis and epidemiology of the syndromes, requires further investigation.
© 2016 The Author(s).

Entities:  

Keywords:  Australia; conjunctivitis; crocodiles; herpesvirus; lymphoproliferation; pathology

Mesh:

Substances:

Year:  2016        PMID: 27075848     DOI: 10.1177/1040638716642268

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  6 in total

1.  Culture-independent metagenomics supports discovery of uncultivable bacteria within the genus Chlamydia.

Authors:  Alyce Taylor-Brown; Labolina Spang; Nicole Borel; Adam Polkinghorne
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

2.  Crocodilepox Virus Evolutionary Genomics Supports Observed Poxvirus Infection Dynamics on Saltwater Crocodile (Crocodylus porosus).

Authors:  Subir Sarker; Sally R Isberg; Jasmin L Moran; Rachel De Araujo; Nikki Elliott; Lorna Melville; Travis Beddoe; Karla J Helbig
Journal:  Viruses       Date:  2019-12-02       Impact factor: 5.048

3.  Coinfection of Chlamydia spp. and herpesvirus in juvenile farmed Siamese crocodiles (Crocodylus siamensis) in Thailand.

Authors:  Weena Paungpin; Metawee Thongdee; Somjit Chaiwattanarungruengpaisan; Ladawan Sariya; Wanna Sirimanapong; Tanit Kasantikul; Rassameepen Phonarknguen; Poonnut Darakamas; Nlin Arya
Journal:  Vet World       Date:  2021-07-25

4.  Dynamic Changes in Host Gene Expression following In Vitro Viral Mimic Stimulation in Crocodile Cells.

Authors:  Subir Sarker; Yinan Wang; Brenden Warren-Smith; Karla J Helbig
Journal:  Front Immunol       Date:  2017-11-22       Impact factor: 7.561

Review 5.  New and emerging chlamydial infections of creatures great and small.

Authors:  A Taylor-Brown; A Polkinghorne
Journal:  New Microbes New Infect       Date:  2017-04-18

6.  Molecular characterization of the first saltwater crocodilepox virus genome sequences from the world's largest living member of the Crocodylia.

Authors:  Subir Sarker; Sally R Isberg; Natalie L Milic; Peter Lock; Karla J Helbig
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.